- Home
- KD vs MEDP Comparison
KD vs MEDP Comparison
Compare KD & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KD
- MEDP
- Stock Information
- Founded
- KD 2020
- MEDP 1992
- Country
- KD United States
- MEDP United States
- Employees
- KD N/A
- MEDP N/A
- Industry
- KD EDP Services
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- KD Technology
- MEDP Health Care
- Exchange
- KD Nasdaq
- MEDP Nasdaq
- Market Cap
- KD 9.6B
- MEDP 8.3B
- IPO Year
- KD N/A
- MEDP 2016
- Fundamental
- Price
- KD $39.73
- MEDP $306.07
- Analyst Decision
- KD Strong Buy
- MEDP Hold
- Analyst Count
- KD 3
- MEDP 10
- Target Price
- KD $43.33
- MEDP $343.22
- AVG Volume (30 Days)
- KD 1.9M
- MEDP 321.8K
- Earning Date
- KD 07-30-2025
- MEDP 07-21-2025
- Dividend Yield
- KD N/A
- MEDP N/A
- EPS Growth
- KD N/A
- MEDP 33.36
- EPS
- KD 1.05
- MEDP 13.09
- Revenue
- KD $15,057,000,000.00
- MEDP $2,156,580,000.00
- Revenue This Year
- KD $6.38
- MEDP $5.59
- Revenue Next Year
- KD $2.58
- MEDP $3.46
- P/E Ratio
- KD $37.83
- MEDP $23.38
- Revenue Growth
- KD N/A
- MEDP 9.87
- 52 Week Low
- KD $21.34
- MEDP $250.05
- 52 Week High
- KD $43.61
- MEDP $459.77
- Technical
- Relative Strength Index (RSI)
- KD 65.53
- MEDP 54.07
- Support Level
- KD $38.14
- MEDP $291.28
- Resistance Level
- KD $39.82
- MEDP $302.32
- Average True Range (ATR)
- KD 0.78
- MEDP 9.09
- MACD
- KD -0.23
- MEDP 0.48
- Stochastic Oscillator
- KD 46.21
- MEDP 82.63
About KD Kyndryl Holdings Inc.
Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives. The company's reportable segments consist of the following: Principal Markets which represents its operations in operations in Australia / New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, and the United Kingdom / Ireland, United States, Japan, and Strategic Markets. It derives maximum revenue from the United States.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the US, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.